Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here’s Why

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals released the results of the long-awaited NASH trial. The results are positive and may lead to accelerated approval. Short-interest remains high and is helping to drive the action. 5 stocks we like better than Madrigal Pharmaceuticals If you want to know why Madrigal Pharmaceuticals (NASDAQ:MDGL) is up 200% in one day, it’s because […]